Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
- PMID: 31396944
- PMCID: PMC6704200
- DOI: 10.1007/s13555-019-00319-0
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Abstract
Facial seborrheic dermatitis (FSD) is a chronic and relapsing inflammatory skin disorder occurring in areas of the face rich in sebaceous glands. It clinically manifests as erythematous scaly macules or plaques, often associated with pruritus. Although the pathogenesis of seborrheic dermatitis is not yet fully understood, Malassezia yeast, hormones, sebum levels, and immune response are known to play important roles. Additional factors including drugs, cold temperatures, and stress may exacerbate the condition. Currently, the available treatments do not cure the disease but relieve symptoms. Various pharmacological treatments are available, including antifungal agents, keratolytics, topical low-potency steroids, and calcineurin inhibitors. All of them provide several benefits, but they also have potential side effects. Seborrheic dermatitis tends to have a chronic, recurrent course. To avoid the long-term use of drugs, topical non-pharmacological products such as cosmetics or medical devices may improve clinical outcomes. Products with antimicrobial and anti-inflammatory ingredients such as zinc, piroctone olamine, dihydroavenanthramide, biosaccharide gum-2, and stearyl glycyrrhetinate may speed FSD recovery and avoid flare-ups. Finally, the use of specific cleansers, moisturizers, and sunscreens formulated as light creams or gel/creams should be strongly recommended to all FSD patients. We provide a brief review of the most used non-pharmacological cleansers, topical gel/creams, and specific sunscreens in the management of FSD.
Keywords: Cosmeceuticals; Cosmetics; Facial; Medical device; Seborrheic dermatitis; Topical treatment.
Conflict of interest statement
Dr. Jaime Piquero-Casals is consultant of ISDIN. Doris Hexsel, Juan Francisco Mir-Bonafé, and Eduardo Rozas-Muñoz have nothing to disclose.
Figures
Similar articles
-
Non-Steroidal Topical Therapy for Facial Seborrheic Dermatitis.J Drugs Dermatol. 2020 Jun 1;19(6):658-660. doi: 10.36849/JDD.2020.10.36849/JDD.2020.5121. J Drugs Dermatol. 2020. PMID: 32574015 Clinical Trial.
-
Facial Seborrheic Dermatitis in HIV-Seropositive Patients: Evaluation of the Efficacy and Safety of a Non-Steroidal Cream Containing Piroctone Olamine, Biosaccharide Gum-2 and Stearyl Glycyrrhetinate - A Case Series.Clin Cosmet Investig Dermatol. 2022 Mar 18;15:483-488. doi: 10.2147/CCID.S344807. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35330623 Free PMC article.
-
Seborrheic dermatitis: an update.Acta Dermatovenerol Croat. 2012;20(2):98-104. Acta Dermatovenerol Croat. 2012. PMID: 22726283 Review.
-
An Overview of the Diagnosis and Management of Seborrheic Dermatitis.Clin Cosmet Investig Dermatol. 2022 Aug 6;15:1537-1548. doi: 10.2147/CCID.S284671. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35967915 Free PMC article. Review.
-
A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.G Ital Dermatol Venereol. 2017 Oct;152(5):436-440. doi: 10.23736/S0392-0488.17.05539-0. Epub 2017 Jan 24. G Ital Dermatol Venereol. 2017. PMID: 28121079 Clinical Trial.
Cited by
-
Pseudohyperaldosteronism Due to Licorice: A Practice-Based Learning from a Case Series.Int J Mol Sci. 2024 Jul 7;25(13):7454. doi: 10.3390/ijms25137454. Int J Mol Sci. 2024. PMID: 39000561 Free PMC article.
-
Promoting public skin health through a national continuing medical education project on cosmetic and dermatologic sciences: a 15-year experience.Front Public Health. 2023 Nov 16;11:1273950. doi: 10.3389/fpubh.2023.1273950. eCollection 2023. Front Public Health. 2023. PMID: 38035281 Free PMC article.
-
Tea Tree Oil: Properties and the Therapeutic Approach to Acne-A Review.Antioxidants (Basel). 2023 Jun 12;12(6):1264. doi: 10.3390/antiox12061264. Antioxidants (Basel). 2023. PMID: 37371994 Free PMC article. Review.
-
[Piroctone olamine disrupts mitochondrial dynamics in glioma cells through the PI3K/AKT pathway].Nan Fang Yi Ke Da Xue Xue Bao. 2023 May 20;43(5):764-771. doi: 10.12122/j.issn.1673-4254.2023.05.12. Nan Fang Yi Ke Da Xue Xue Bao. 2023. PMID: 37313818 Free PMC article. Chinese.
-
Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients.Arch Dermatol Res. 2023 Aug;315(6):1497-1509. doi: 10.1007/s00403-022-02506-0. Epub 2022 Dec 14. Arch Dermatol Res. 2023. PMID: 36517586 Free PMC article. Review.
References
-
- Bukvic ZM, Kralj M, Basta-Juzbasic A, Lakos J. Seborrhoeic dermatitis: an update. Acta Dermatovenerol Croat. 2012;20(2):98–104. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
